G protein-coupled receptor kinase 6 deficiency promotes angiogenesis, tumor progression, and metastasis

Journal of Immunology

Volumn 190, Issue 10, 2013, Pages 5329-5336

  Raghuwanshi, Sandeep K ^a   Smith, Nikia ^a   Rivers, Elizabeth J ^a   Thomas, Ariel J ^a   Sutton, Natalie ^a   Hu, Yuhui ^a   Mukhopadhyay, Somnath ^a   Chen, Xiaoxin L ^a   Leung, TinChung ^a,b   Richardson, Ricardo M ^a  

^a NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 BROMOPHENYL) 3 (2 HYDROXY 4 NITROPHENYL)UREA; BETA ARRESTIN 2; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR2 ANTAGONIST; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; G PROTEIN COUPLED RECEPTOR KINASE 6; GELATINASE A; GELATINASE B; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEEDBACK SYSTEM; FEMALE; LEWIS CARCINOMA; MALE; METASTASIS; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR REGRESSION; TUMOR VASCULARIZATION; UPREGULATION;

ANIMALS; ARRESTINS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; CHEMOTAXIS; DISEASE PROGRESSION; DOWN-REGULATION; G-PROTEIN-COUPLED RECEPTOR KINASES; GENOTYPE; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, KNOCKOUT; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; NEUTROPHILS; PHENYLUREA COMPOUNDS; PHOSPHORYLATION; RECEPTORS, INTERLEUKIN-8B; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; UP-REGULATION; WOUND HEALING;

EID: 84877836566     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202058     Document Type: Article

References (48)

1. Vroon, A., C. J. Heijnen, and A. Kavelaars. 2006. GRKs and arrestins: regulators of migration and inflammation. J. Leukoc. Biol. 80: 1214-1221. (Pubitemid 44904958)
2. Reiter, E., and R. J. Lefkowitz. 2006. GRKs and beta-Arrestins: roles in receptor silencing, trafficking and signaling. Trends Endocrinol. Metab. 17: 159-165.
3. Pitcher, J. A., N. J. Freedman, and R. J. Lefkowitz. 1998. G protein-coupled receptor kinases. Annu. Rev. Biochem. 67: 653-692. (Pubitemid 28411141)
4. Koch, W. J., J. Inglese, W. C. Stone, and R. J. Lefkowitz. 1993. The binding site for the beta gamma subunits of heterotrimeric G proteins on the beta-Adrenergic receptor kinase. J. Biol. Chem. 268: 8256-8260. (Pubitemid 23120415)
5. Luttrell, L. M., B. E. Hawes, K. Touhara, T. van Biesen, W. J. Koch, and R. J. Lefkowitz. 1995. Effect of cellular expression of pleckstrin homology domains on Gi-coupled receptor signaling. J. Biol. Chem. 270: 12984-12989.
6. Eichmann, T., K. Lorenz, M. Hoffmann, J. Brockmann, C. Krasel,M. J. Lohse, and U. Quitterer. 2003. The amino-terminal domain of G-protein-coupled receptor kinase 2 is a regulatory Gbeta gamma binding site. J. Biol. Chem. 278: 8052-8057. (Pubitemid 36800544)
7. Premont, R. T., A. D. Macrae, R. H. Stoffel, N. Chung, J. A. Pitcher, C. Ambrose, J. Inglese, M. E. MacDonald, and R. J. Lefkowitz. 1996. Characterization of the G protein-coupled receptor kinase GRK4. Identification of four splice variants. J. Biol. Chem. 271: 6403-6410.
8. Premont, R. T., W. J. Koch, J. Inglese, and R. J. Lefkowitz. 1994. Identification, purification, and characterization of GRK5, a member of the family of G proteincoupled receptor kinases. J. Biol. Chem. 269: 6832-6841. (Pubitemid 24191077)
9. Stoffel, R. H., R. R. Randall, R. T. Premont, R. J. Lefkowitz, and J. Inglese. 1994. Palmitoylation of G protein-coupled receptor kinase, GRK6. Lipid modification diversity in the GRK family. J. Biol. Chem. 269: 27791-27794.
10. Baggiolini, M., B. Dewald, and B. Moser. 1997. Human chemokines: an update. Annu. Rev. Immunol. 15: 675-705. (Pubitemid 27169296)
11. Murphy, P. M., M. Baggiolini, I. F. Charo, C. A. Hébert, R. Horuk, K. Matsushima, L. H. Miller, J. J. Oppenheim, and C. A. Power. 2000. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52: 145-176. (Pubitemid 30127598)
12. Strieter, R. M., P. J. Polverini, S. L. Kunkel, D. A. Arenberg, M. D. Burdick, J. Kasper, J. Dzuiba, J. Van Damme, A. Walz, D. Marriott, et al. 1995. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270: 27348-27357.
13. Strieter, R. M., M. D. Burdick, J. Mestas, B. Gomperts, M. P. Keane, and J. A. Belperio. 2006. Cancer CXC chemokine networks and tumour angiogenesis. Eur. J. Cancer 42: 768-778.
14. Richardson, R. M., B. C. Pridgen, B. Haribabu, H. Ali, and R. Snyderman. 1998. Differential cross-regulation of the human chemokine receptors CXCR1 and CXCR2. Evidence for time-dependent signal generation. J. Biol. Chem. 273: 23830-23836. (Pubitemid 28435718)
15. Richardson, R. M., R. J. Marjoram, L. S. Barak, and R. Snyderman. 2003. Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911. (Pubitemid 36302161)
16. Fan, G. H., W. Yang, X. J.Wang, Q. Qian, and A. Richmond. 2001. Identification of a motif in the carboxyl terminus of CXCR2 that is involved in adaptin 2 binding and receptor internalization. Biochemistry 40: 791-800. (Pubitemid 32096864)
17. Nasser, M. W., R. J. Marjoram, S. L. Brown, and R. M. Richardson. 2005. Crossdesensitization among CXCR1, CXCR2, and CCR5: role of protein kinase Cepsilon. J. Immunol. 174: 6927-6933.
18. Richardson, R. M., R. A. DuBose, H. Ali, E. D. Tomhave, B. Haribabu, and R. Snyderman. 1995. Regulation of human interleukin-8 receptor A: identification of a phosphorylation site involved in modulating receptor functions. Biochemistry 34: 14193-14201.
19. Raghuwanshi, S. K., Y. Su, V. Singh, K. Haynes, A. Richmond, and R. M. Richardson. 2012. The chemokine receptors CXCR1 and CXCR2 couple to distinct G protein-coupled receptor kinases to mediate and regulate leukocyte functions. J. Immunol. 189: 2824-2832.
20. Su, Y., S. K. Raghuwanshi, Y. Yu, L. B. Nanney, R. M. Richardson, and A. Richmond. 2005. Altered CXCR2 signaling in beta-Arrestin-2-deficient mouse models. J. Immunol. 175: 5396-5402. (Pubitemid 41456426)
21. Raghuwanshi, S. K., M. W. Nasser, X. Chen, R.M. Strieter, and R.M. Richardson. 2008. Depletion of beta-Arrestin-2 promotes tumor growth and angiogenesis in a murine model of lung cancer. J. Immunol. 180: 5699-5706.
22. Fong, A. M., R. T. Premont, R. M. Richardson, Y. R. Yu, R. J. Lefkowitz, and D. D. Patel. 2002. Defective lymphocyte chemotaxis in beta-Arrestin2-And GRK6-deficient mice. Proc. Natl. Acad. Sci. USA 99: 7478-7483. (Pubitemid 34568716)
23. Keane, M. P., J. A. Belperio, Y. Y. Xue, M. D. Burdick, and R. M. Strieter. 2004. Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer. J. Immunol. 172: 2853-2860. (Pubitemid 38263670)
24. Elkin, M., and I. Vlodavsky. 2001. Tail vein assay of cancer metastasis. Curr. Protoc. Cell Biol. Chapter 19:Unit 19.2.
25. Schmalfeldt, B., D. Prechtel, K. Harting, K. Spathe, S. Rutke, E. Konik, R. Fridman, U. Berger, M. Schmitt, W. Kuhn, and E. Lengyel. 2001. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinasetype plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin. Cancer Res. 7: 2396-2404. (Pubitemid 32751641)
26. Murase, S., and R. D. McKay. 2012. Matrix metalloproteinase-9 regulates survival of neurons in newborn hippocampus. J. Biol. Chem. 287: 12184-12194.
27. Arenberg, D. A., S. L. Kunkel, P. J. Polverini, M. Glass, M. D. Burdick, and R. M. Strieter. 1996. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J. Clin. Invest. 97: 2792-2802. (Pubitemid 26197092)
28. Varney, M. L., S. L. Johansson, and R. K. Singh. 2006. Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma. Am. J. Clin. Pathol. 125: 209-216. (Pubitemid 43167161)
29. Varney, M. L., A. Li, B. J. Dave, C. D. Bucana, S. L. Johansson, and R. K. Singh. 2003. Expression of CXCR1 and CXCR2 receptors in malignant melanoma with different metastatic potential and their role in interleukin-8 (CXCL-8)-mediated modulation of metastatic phenotype. Clin. Exp. Metastasis 20: 723-731. (Pubitemid 38019274)
30. Eck, M., B. Schmausser, K. Scheller, S. Brandlein, and H. K. Muller-Hermelink. 2003. Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma. Clin. Exp. Immunol. 134: 508-515. (Pubitemid 37542093)
31. Zhu, Y. M., S. J. Webster, D. Flower, and P. J. Woll. 2004. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells. Br. J. Cancer 91: 1970-1976. (Pubitemid 40065527)
32. Wislez, M., N. Fujimoto, J. G. Izzo, A. E. Hanna, D. D. Cody, R. R. Langley, H. Tang, M. D. Burdick, M. Sato, J. D. Minna, et al. 2006. High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras. Cancer Res. 66: 4198-4207.
33. Singh, S., M. Varney, and R. K. Singh. 2009. Host CXCR2-dependent regulation of melanoma growth, angiogenesis, and experimental lung metastasis. Cancer Res. 69: 411-415.
34. Mestas, J., M. D. Burdick, K. Reckamp, A. Pantuck, R. A. Figlin, and R. M. Strieter. 2005. The role of CXCR2/CXCR2 ligand biological axis in renal cell carcinoma. J. Immunol. 175: 5351-5357. (Pubitemid 41456421)
35. + CXC chemokineinduced angiogenic activity. J. Immunol. 165: 5269-5277.
36. Heidemann, J., H. Ogawa, M. B. Dwinell, P. Rafiee, C. Maaser, H. R. Gockel, M. F. Otterson, D. M. Ota, N. Lugering, W. Domschke, and D. G. Binion. 2003. Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2. J. Biol. Chem. 278: 8508-8515. (Pubitemid 36800603)
37. Sang, Q. X. A. 1998. Complex role of matrix metalloproteinases in angiogenesis. Cell Res. 8: 171-177. (Pubitemid 128544277)
38. Rundhaug, J. E. 2003. Matrix metalloproteinases, angiogenesis, and cancer: commentary re: A. C. Lockhart et al., Reduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor. Clin. Cancer Res., 9: 00-00, 2003.
39. Clin. Cancer Res. 9: 551-554.
40. Rundhaug, J. E. 2005. Matrix metalloproteinases and angiogenesis. J. Cell. Mol. Med. 9: 267-285.
41. Li, A., S. Dubey, M. L. Varney, B. J. Dave, and R. K. Singh. 2003. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J. Immunol. 170: 3369-3376. (Pubitemid 36302216)
42. Li, A., M. L. Varney, J. Valasek, M. Godfrey, B. J. Dave, and R. K. Singh. 2005. Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis. Angiogenesis 8: 63-71. (Pubitemid 41223840)
43. Chiou, S. H., B. C. Sheu, W. C. Chang, S. C. Huang, and H. Hong-Nerng. 2005. Current concepts of tumor-infiltrating lymphocytes in human malignancies. J. Reprod. Immunol. 67: 35-50.
44. Scapini, P., J. A. Lapinet-Vera, S. Gasperini, F. Calzetti, F. Bazzoni, and M. A. Cassatella. 2000. The neutrophil as a cellular source of chemokines. Immunol. Rev. 177: 195-203.
45. Scapini, P., M. Morini, C. Tecchio, S. Minghelli, E. Di Carlo, E. Tanghetti, A. Albini, C. Lowell, G. Berton, D. M. Noonan, and M. A. Cassatella. 2004. CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A. J. Immunol. 172: 5034-5040. (Pubitemid 38456430)
46. Fu, W., Y. Zhang, J. Zhang, and W.-F. Chen. 2005. Cloning and characterization of mouse homolog of the CXC chemokine receptor CXCR1. Cytokine 31: 9-17. (Pubitemid 40828354)
47. Moepps, B., E. Nuesseler, M. Braun, and P. Gierschik. 2006. A homolog of the human chemokine receptor CXCR1 is expressed in the mouse. Mol. Immunol. 43: 897-914. (Pubitemid 41814408)
48. Fan, X., A. C. Patera, A. Pong-Kennedy, G. Deno, W. Gonsiorek, D. J. Manfra, G. Vassileva, M. Zeng, C. Jackson, L. Sullivan, et al. 2007. Murine CXCR1 is a functional receptor for GCP-2/CXCL6 and interleukin-8/CXCL8. J. Biol. Chem. 282: 11658-11666. (Pubitemid 47100704)